tiprankstipranks
Dyne Therapeutics (DYN)
NASDAQ:DYN
US Market
DYN
Dyne Therapeutics
RESEARCH TOOLSreports
Want to see DYN full AI Analyst Report?

Dyne Therapeutics (DYN) Financial Statements

457 Followers

Dyne Therapeutics Financial Overview

Dyne Therapeutics's market cap is currently $2.88B. The company's EPS TTM is $; its P/E ratio is -5.63; Dyne Therapeutics is scheduled to report earnings on April 30, 2026, and the estimated EPS forecast is $-0.77. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -2.05M$ -2.24M$ -2.46M$ 0.00$ 0.00
Operating Income$ -468.18M$ -343.89M$ -242.16M$ -170.96M$ -150.03M
EBITDA$ -437.97M$ -315.18M$ -233.48M$ -169.28M$ -148.94M
Net Income$ -446.21M$ -317.42M$ -235.94M$ -168.10M$ -149.29M
Balance Sheet
Cash & Short-Term Investments$ 1.11B$ 642.27M$ 123.10M$ 256.01M$ 376.57M
Total Assets$ 1.19B$ 691.23M$ 165.08M$ 306.32M$ 425.66M
Total Debt$ 20.28M$ 23.99M$ 27.41M$ 30.48M$ 32.64M
Net Debt$ -873.09M$ -411.46M$ -94.21M$ -141.66M$ -168.19M
Total Liabilities$ 214.83M$ 61.40M$ 73.79M$ 53.96M$ 57.47M
Stockholders' Equity$ 972.13M$ 629.84M$ 91.29M$ 252.36M$ 368.20M
Cash Flow
Free Cash Flow$ -405.13M$ -294.75M$ -188.89M$ -156.71M$ -123.18M
Operating Cash Flow$ -403.21M$ -292.37M$ -188.16M$ -153.65M$ -119.56M
Investing Cash Flow$ -28.75M$ -204.08M$ 83.31M$ 87.20M$ -137.89M
Financing Cash Flow$ 890.31M$ 809.89M$ 54.32M$ 37.39M$ 157.82M
Currency in USD

Dyne Therapeutics Earnings and Revenue History

Income Statement >

Dyne Therapeutics Debt to Assets

Balance Sheet >

Dyne Therapeutics Cash Flow

Cash Flow >

Dyne Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
Earnings >